Fulgent Genetics, Inc. FLGT Other Commercial Liabilities
Other Commercial Liabilities at other companies
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Fulgent Genetics, Inc.'s other commercial liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Fulgent Genetics, Inc.'s other commercial liabilities?
- Fulgent Genetics, Inc. (FLGT) reported other commercial liabilities of $34.9M in Q1 2026.
- How has Fulgent Genetics, Inc.'s other commercial liabilities changed year-over-year?
- Fulgent Genetics, Inc.'s other commercial liabilities increased by 109.1% year-over-year, from $16.69M to $34.9M.
- What is the long-term trend for Fulgent Genetics, Inc.'s other commercial liabilities?
- Over 5 years (2020 to 2025), Fulgent Genetics, Inc.'s other commercial liabilities has grown at a 32.2% compound annual growth rate (CAGR), from $8.45M to $34.06M.